APR 01, 2020 7:04 PM PDT

How Two Types of Tests for COVID-19 Work

WRITTEN BY: Carmen Leitch

There are a couple of different kinds of tests that researchers have developed (and will continue to improve) and clinicians will be using to disrupt the COVID-19 pandemic. One will rely on detecting the genetic material of the virus, while the other will be based on the body's immune response to the virus. The Report from the American Society for Microbiology COVID-19 International Summit has been published in mBio, and has outlined the various aspects of these testing platforms.

There have been many missed opportunities to control the spread of SARS-CoV-2. Now that we're dealing with a pandemic, the ideal approach would be to test everyone, isolate those that carry the virus and are contagious, and treat the sick. Contact tracing could be employed and people that were at risk could also be tested or quarantined as needed. Another option would be to test everyone to see who had been exposed, gained immunity and wasn't contagious, so they could go about their lives. Obviously, we don't have the testing resources that would be necessary for such massive operations.

Instead, we have to use the available tests and resources. One testing method directly identifies the virus. These tests typically amplify viral RNA using PCR, a reaction that scales up the level of the genetic material under study. One caveat is that viral RNA has to be present in the sample that's collected in order for the test to be useful as a diagnostic tool, and that may not always be the case for every patient with a SARS-CoV-2 infection. Some with pneumonia, for example, may not carry viral RNA in their upper respiratory tract. Another potential issue is sample quality; RNA can be susceptible to degradation.

Colorized scanning electron micrograph of a VERO E6 cell (blue) heavily infected with SARS-COV-2 virus particles (orange), isolated from a patient sample. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. / Credit: NIAID

The study notes that these viral RNA-based tests are still the best option we have for diagnosing acute infections. They are necessary to inform patients and healthcare providers about the situation with patients in the clinic and their options. The authors wrote that testing should be broadly applied, and available to anyone exhibiting COVID-19 symptoms and more generally to health care workers and patients in long-term care.

"Additionally, as testing increases, decreasing the time to results of testing will continue to be crucial to better manage both patients and health care workers," they noted. In other words, we need the results of those tests right away.

The other testing approach relies on the detection of antibodies made by the body after it senses a SARS-CoV-2 infection. It's thought that most people develop detectable levels of these antibodies, so-called seroconversion, seven to eleven days after they are exposed to the virus, and potentially sooner. Since there is a delay of a few days, these tests are not good for the clinic. Instead, they serve public health purposes.

Tests for SARS-CoV-2/COVID-19 and potential uses. / Credit: Patel et al mBio 2020

While we have not yet confirmed that people who have been exposed to the virus have acquired immunity, we do know that the virus has not mutated much since it has started spreading. Some experts believe that people cannot be reinfected and that isolated reports of reinfection may have more to do with testing errors. If people that are exposed have become immune, their serum may help those that are fighting the infection. They are also useful as a validating tool for the PCR-based assay.

Sources: AAAS/Eurekalert! via American Society for Microbiology, mBio

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
MAR 23, 2020
Microbiology
MAR 23, 2020
The Loss of a Sense of Smell May be a Major Symptom of COVID-19
The loss of the sense of smell may be a symptom of a COVID-19 infection in people with no other symptoms.
MAR 26, 2020
Microbiology
MAR 26, 2020
US Now Leads the World in Coronavirus Cases
In the United States, there have been 83,836 confirmed cases of COVID-19, and over 529,000 worldwide.
APR 08, 2020
Microbiology
APR 08, 2020
How the Vaginal Microbiome is Connected to Preterm Delivery
New research has connected the composition of the community of microbes that populates the vagina with premature birth.
MAY 05, 2020
Immunology
MAY 05, 2020
Winter the Llama: An Unlikely Hero in the Fight Against COVID-19
A new hero in the fight against COVID-19 has emerged: 4-year-old Winter, a llama that currently resides in the Belgian c ...
MAY 04, 2020
Neuroscience
MAY 04, 2020
Certain Gut Bacteria Improves Memory in Mice
Researchers from the US Department of Energy national laboratories have found that certain gut bacteria are able to impr ...
MAY 25, 2020
Microbiology
MAY 25, 2020
The Symbiotic Bacteria That Stow Away in Ship-Destroying Clams
Shipworms are known as the 'termites of the sea.' They are not actually worms; these infamous mollusks that have brought ...
Loading Comments...